Immix Biopharma Stock (NASDAQ: IMMX) stock price, news, charts, stock research, profile.
You can purchase shares of Immix Biopharma (NASDAQ:IMMX) through any online brokerage.
Other companies in Immix Biopharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Fortress Biotech (NASDAQ:FBIO), CytomX Therapeutics (NASDAQ:CTMX), Gain Therapeutics (NASDAQ:GANX) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Immix Biopharma has a consensus price target of $10.50.
The stock price for Immix Biopharma (NASDAQ: IMMX) is $1.95 last updated January 17, 2025 at 7:00 PM EST.
There are no upcoming dividends for Immix Biopharma.
Immix Biopharma’s Q4 earnings are confirmed for Friday, March 28, 2025.
There is no upcoming split for Immix Biopharma.
Immix Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.